198 related articles for article (PubMed ID: 19786256)
21. [Invasive diagnostic technique for heart failure].
Takeuchi M
Nihon Rinsho; 1993 May; 51(5):1255-9. PubMed ID: 8331793
[TBL] [Abstract][Full Text] [Related]
22. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Elkayam U; Akhter MW; Singh H; Khan S; Usman A
Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
Ng TM; Ackerbauer KA; Hyderi AF; Hshieh S; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):79-85. PubMed ID: 21536855
[TBL] [Abstract][Full Text] [Related]
24. Changes in left ventricular preload, afterload, and cardiac output in response to a single dose of mannitol in neurosurgical patients undergoing craniotomy: a transesophageal echocardiographic study.
Chatterjee N; Koshy T; Misra S; Suparna B
J Neurosurg Anesthesiol; 2012 Jan; 24(1):25-9. PubMed ID: 21959682
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure.
Baur LH; Schipperheyn JJ; Cats VM; van der Wall EE; Baan J; van Dijk AD; Bruschke AV
Eur Heart J; 1992 Nov; 13 Suppl E():52-6. PubMed ID: 1478210
[TBL] [Abstract][Full Text] [Related]
26. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
[TBL] [Abstract][Full Text] [Related]
27. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.
Vaitkevicius PV; Lane M; Spurgeon H; Ingram DK; Roth GS; Egan JJ; Vasan S; Wagle DR; Ulrich P; Brines M; Wuerth JP; Cerami A; Lakatta EG
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1171-5. PubMed ID: 11158613
[TBL] [Abstract][Full Text] [Related]
28. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension.
Kelesidis I; Mazurek JA; Saeed W; Chaudhari R; Velankar P; Zolty R
Congest Heart Fail; 2012; 18(1):18-24. PubMed ID: 22277173
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular function by pressure-volume loop analysis before and after percutaneous repair of large atrial septal defects.
Lim DS; Gutgesell HP; Rocchini AP
J Interv Cardiol; 2014 Apr; 27(2):204-11. PubMed ID: 18248358
[TBL] [Abstract][Full Text] [Related]
30. [Invasive diagnostic technique and technology for heart failure].
Shinke T; Watanabe S; Yokoyama M
Nihon Rinsho; 2006 May; 64(5):883-9. PubMed ID: 16689369
[TBL] [Abstract][Full Text] [Related]
31. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T
Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948
[TBL] [Abstract][Full Text] [Related]
32. Nesiritide: a new drug for the treatment of decompensated heart failure.
Elkayam U; Akhter MW; Tummala P; Khan S; Singh H
J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):181-94. PubMed ID: 12232567
[TBL] [Abstract][Full Text] [Related]
33. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
Michaels AD; Klein A; Madden JA; Chatterjee K
Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular responses to acute changes in late systolic pressure augmentation in older adults.
Sweitzer NK; Hetzel SJ; Skalski J; Velez M; Eggleston K; Mitchell GF
Am J Hypertens; 2013 Jul; 26(7):866-71. PubMed ID: 23537892
[TBL] [Abstract][Full Text] [Related]
35. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
Abraham WT; Cheng ML; Smoluk G;
Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
[TBL] [Abstract][Full Text] [Related]
36. Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance.
Haber HL; Simek CL; Bergin JD; Sadun A; Gimple LW; Powers ER; Feldman MD
J Am Coll Cardiol; 1993 Jul; 22(1):251-7. PubMed ID: 8509548
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.
Butler J; Emerman C; Peacock WF; Mathur VS; Young JB;
Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964
[TBL] [Abstract][Full Text] [Related]
38. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
Peacock WF; Fonarow GC; Emerman CL; Mills RM; Wynne J; ;
Cardiology; 2007; 107(1):44-51. PubMed ID: 16741357
[TBL] [Abstract][Full Text] [Related]
39. Direct myocardial effects of OPC-18790 in human heart failure: beneficial effects on contractile and diastolic function demonstrated by intracoronary infusion with pressure-volume analysis.
MacGowan GA; Haber HL; Cowart TD; Tedesco C; Wu C; Feldman MD
J Am Coll Cardiol; 1998 May; 31(6):1344-51. PubMed ID: 9581731
[TBL] [Abstract][Full Text] [Related]
40. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
